124 related articles for article (PubMed ID: 19725798)
21. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
22. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
[TBL] [Abstract][Full Text] [Related]
23. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
24. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
[TBL] [Abstract][Full Text] [Related]
25. Costs for patients with psychotic illness: differences depending upon state of remission.
Hjortsberg C; Helldin L; Hjaerthag F; Loethgren M
J Ment Health Policy Econ; 2011 Jun; 14(2):87-93. PubMed ID: 21881164
[TBL] [Abstract][Full Text] [Related]
26. The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit.
Ara RM; Packham JC; Haywood KL
Rheumatology (Oxford); 2008 Jan; 47(1):68-71. PubMed ID: 18077492
[TBL] [Abstract][Full Text] [Related]
27. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
[TBL] [Abstract][Full Text] [Related]
28. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
29. Economics and schizophrenia: the real cost.
Davies LM; Drummond MF
Br J Psychiatry Suppl; 1994 Nov; (25):18-21. PubMed ID: 7865193
[TBL] [Abstract][Full Text] [Related]
30. Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009.
Meier GC; Watkins J; McEwan P; Pockett RD
PLoS One; 2020; 15(8):e0236472. PubMed ID: 32760071
[TBL] [Abstract][Full Text] [Related]
31. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
32. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
33. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.
Schreiber-Katz O; Klug C; Thiele S; Schorling E; Zowe J; Reilich P; Nagels KH; Walter MC
Orphanet J Rare Dis; 2014 Dec; 9():210. PubMed ID: 25519771
[TBL] [Abstract][Full Text] [Related]
34. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
35. Finding Rheumatoid Arthritis Impact on Life (FRAIL Study): economic burden.
Miranda LC; Santos H; Ferreira J; Coelho P; Silva C; Saraiva-Ribeiro J;
Acta Reumatol Port; 2012; 37(2):134-42. PubMed ID: 23149635
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
37. Household costs of mental health care in Ghana.
Addo R; Nonvignon J; Aikins M
J Ment Health Policy Econ; 2013 Dec; 16(4):151-9. PubMed ID: 24526584
[TBL] [Abstract][Full Text] [Related]
38. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
39. Asthma severity and medical resource utilisation.
Antonicelli L; Bucca C; Neri M; De Benedetto F; Sabbatani P; Bonifazi F; Eichler HG; Zhang Q; Yin DD
Eur Respir J; 2004 May; 23(5):723-9. PubMed ID: 15176687
[TBL] [Abstract][Full Text] [Related]
40. Direct medical costs associated with atopic diseases among young children in Thailand.
Ngamphaiboon J; Kongnakorn T; Detzel P; Sirisomboonwong K; Wasiak R
J Med Econ; 2012; 15(6):1025-35. PubMed ID: 22642533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]